Skip to main content
SpringerLink
Log in

Letter to the Editor of Annals of Surgical Oncology Concerning “Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA”

  • Peritoneal Surface Malignancy
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Alyami M, Bonnot P-E, Mercier F, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer. Eur J Surg Oncol. 2021;47(1):123–7. https://doi.org/10.1016/j.ejso.2020.05.021.

    Article  PubMed  Google Scholar 

  2. Solass W, Giger-Pabst U, Zieren J, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects. Ann Surg Oncol. 2013;20(11):3504–11. https://doi.org/10.1245/s10434-013-3039-x.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Jansen-Winkeln B, Eberth J, Moulla Y, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study. J Cancer Res Clin Oncol. 2023;149(3):1331–41. https://doi.org/10.1007/s00432-022-04517-w.

    Article  CAS  PubMed  Google Scholar 

  4. Weber JS, Levit LA, Adamson PC, et al. American Society of Clinical Oncology Policy Statement Update: the critical role of phase I trials in cancer research and treatment. J Clin Oncol. 2015;33(3):278–84. https://doi.org/10.1200/JCO.2014.58.2635.

    Article  PubMed  Google Scholar 

  5. Verweij J, Hendriks HR, Zwierzina H, et al. Innovation in oncology clinical trial design. Cancer Treat Rev. 2019;74:15–20. https://doi.org/10.1016/j.ctrv.2019.01.001.

    Article  CAS  PubMed  Google Scholar 

  6. Taibi A, Sgarbura O, Hübner M. ASO Author reflections: developing next-generation intraperitoneal chemotherapy. Ann Surg Oncol. 2021;28(7):3861–2. https://doi.org/10.1245/s10434-020-09377-7.

    Article  PubMed  Google Scholar 

  7. Sgarbura O, Eveno C, Alyami M, et al. Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC). Pleura Peritoneum. 2022;7(1):1–7. https://doi.org/10.1515/pp-2022-0102.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Raoof M, Whelan RL, Sullivan KM, et al. Safety and efficacy of oxaliplatin pressurized intraperitoneal aerosolized chemotherapy (PIPAC) in colorectal and appendiceal cancer with peritoneal metastases: results of a multicenter phase I trial in the USA. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13941-2.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Baggaley AE, Lafaurie GBRC, Tate SJ, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): updated systematic review using the IDEAL framework. Br J Surg. 2022;110(1):10–8. https://doi.org/10.1093/bjs/znac284.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Robella M, Hubner M, Sgarbura O, et al. Feasibility and safety of PIPAC combined with additional surgical procedures: PLUS study. Eur J Surg Oncol. 2022;48(10):2212–7. https://doi.org/10.1016/j.ejso.2022.05.001.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan

    Chong-Chi Chiu MD

  2. Department of Medical Education and Research, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan

    Chong-Chi Chiu MD

  3. School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan

    Chong-Chi Chiu MD

Authors
  1. Chong-Chi Chiu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chong-Chi Chiu MD.

Ethics declarations

Disclosure

The author declares that he has no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chiu, CC. Letter to the Editor of Annals of Surgical Oncology Concerning “Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA”. Ann Surg Oncol 31, 2405–2407 (2024). https://doi.org/10.1245/s10434-023-14595-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14595-w

Search

Navigation